Universal Beteiligungs und Servicegesellschaft mbH Buys Shares of 82,986 Henry Schein, Inc. (NASDAQ:HSIC)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 82,986 shares of the company's stock, valued at approximately $5,743,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.07% of Henry Schein at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of HSIC. Jefferies Financial Group Inc. lifted its position in shares of Henry Schein by 98.8% during the fourth quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company's stock worth $5,751,000 after purchasing an additional 41,300 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Henry Schein by 97.2% in the fourth quarter. Mackenzie Financial Corp now owns 8,819 shares of the company's stock valued at $610,000 after buying an additional 4,348 shares during the period. Forum Financial Management LP bought a new position in shares of Henry Schein in the fourth quarter valued at $221,000. Toronto Dominion Bank boosted its holdings in shares of Henry Schein by 6.7% in the fourth quarter. Toronto Dominion Bank now owns 66,997 shares of the company's stock worth $4,636,000 after buying an additional 4,218 shares during the period. Finally, GF Fund Management CO. LTD. acquired a new stake in shares of Henry Schein during the 4th quarter valued at $194,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on HSIC. Piper Sandler reduced their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Barrington Research lowered their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Wells Fargo & Company decreased their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Finally, Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Insiders Place Their Bets

In related news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Trading Down 2.9%

NASDAQ HSIC traded down $2.12 during trading hours on Friday, hitting $69.86. The company's stock had a trading volume of 3,123,095 shares, compared to its average volume of 1,672,150. The stock has a fifty day moving average of $67.65 and a 200 day moving average of $71.69. The firm has a market capitalization of $8.50 billion, a P/E ratio of 28.75, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the company earned $1.10 EPS. The firm's revenue was down .1% on a year-over-year basis. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.